Clinical Trial Update: A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of evofosfamide in combination with zalifrelimab and balstilimab is currently recruiting for metastatic prostate cancer, metastatic head and n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Evofosfamide (evofosfamide)
• Zalifrelimab (zalifrelimab)

Snippet

Sponsor: ImmunoGenesis | Conditions: Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING